GERON CORP GERN (NASDAQ)

$ 4.37
19:10
Change: unch (unch%)
Volume: 680,247

Avg. Volume: 707137
P/E Ratio: 0
EPS (Annual): -0.76
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 76,470
Institutional Shareholders: 23.39%
Last: 4.37
Change: unch (unch%)
Prev. Close: 4.37
Open: 4.37
Day's Range: 4.31 - 4.55
52wk Range: 3.14 - 8.30
Market Value: 289,020
Beta: 1.76
12-month EPS Change: 0.00%
Total Return Last 12 Months: -38.52%
Total Return Last 3 Years: -72.69%
Total Return Last 5 Years: -44.92%
5-Year Revenue Growth Rate: 510.74%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: -54.74%


Headlines on GERN

Geron shares recover after drop on study delay

(NEW YORK)Shares of biotechnology company Geron Corp. regained some ground Thursday, following a prior-day plunge on the Food and Drug Administration's decision to place a clinical hold ...READ MORE
May 15, 2008 5:55PM
Keywords: GERN, STEM, OSIR, GENZ, MRK, CYTX
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +6.50 53.92
GILEAD SCIENCES +37.60 52.70
GENENTECH INC +36.30 93.73
CELGENE CP +22.00 70.45
BIOGEN IDEC INC +29.90 71.38